Sundrug Co.,Ltd. (TYO:9989)
4,435.00
+127.00 (2.95%)
Nov 21, 2025, 3:30 PM JST
Sundrug Revenue
Sundrug had revenue of 210.74B JPY in the quarter ending September 30, 2025, with 4.83% growth. This brings the company's revenue in the last twelve months to 824.66B, up 6.32% year-over-year. In the fiscal year ending March 31, 2025, Sundrug had annual revenue of 801.81B with 6.66% growth.
Revenue (ttm)
824.66B
Revenue Growth
+6.32%
P/S Ratio
0.63
Revenue / Employee
115.42M
Employees
7,145
Market Cap
518.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 801.81B | 50.03B | 6.66% |
| Mar 31, 2024 | 751.78B | 61.32B | 8.88% |
| Mar 31, 2023 | 690.46B | 41.73B | 6.43% |
| Mar 31, 2022 | 648.73B | 14.42B | 2.27% |
| Mar 31, 2021 | 634.31B | 16.54B | 2.68% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |